We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Defective Cell Extrusion May Lead to Formation of Tumors in Pancreas, Lungs, or Colon

By LabMedica International staff writers
Posted on 09 Feb 2015
Print article
The disruption of normal S1P2 (sphingosine-1-phosphate receptor 2) receptor activity in epithelial cells prevents the pro-apoptotic extrusion of cells from overcrowded tissue and leads to the formation of cancerous growths in the pancreas, lung, and colon.

When epithelial tissues become too crowded, some cells are extruded that later die. To extrude, a cell produces the lipid, sphingosine 1-phosphate (S1P), which activates S1P2 receptors in neighboring cells that seamlessly squeeze the cell out of the epithelium. Tumors or epithelia lacking S1P2 cannot extrude cells in the normal fashion, which can contribute to carcinogenesis and tumor progression.

Investigators at the University of Utah (Salt Lake City, USA) studied the extrusion process in a zebrafish model system. They reported in the January 26, 2015, online edition of the journal eLife that when S1P2 signaling was disrupted, cells built up and formed masses that resisted apoptosis—even when it was triggered by chemotherapy—or they slipped into underlying tissues where they could potentially begin to grow. Furthermore, some cells died without being extruded, creating poor barrier function in the epithelium, which could cause chronic inflammation.

Inducing S1P2 expression was found to be sufficient to restore extrusion and cell death and reduced pancreatic tumors and their metastases. An inhibitor of the enzyme FAK (focal adhesion kinase) was found to enable cells to bypass extrusion defects and could, therefore, target pancreatic, lung, and colon tumors that lacked S1P2 without affecting normal tissues.

"This kind of altered extrusion may be a common hallmark of invasive tumor types," said senior author Dr. Jody Rosenblatt, associate professor of oncological sciences at the University of Utah. "While the mechanisms that drive tumor cell invasion are not yet clear, the results suggest that S1P2-mediated extrusion may play an important role in metastatic cell invasion. Some FAK inhibitors are already being tested in clinical trials for other types of cancers. Hopefully, they may also be a better therapy for recalcitrant tumors such as pancreas cancers and some lung cancers."

Related Links:

University of Utah


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The cobas Malaria test is the first FDA-approved molecular test to screen U.S. blood donors for malaria (Photo courtesy of Roche)

First FDA-Approved Molecular Test to Screen Blood Donors for Malaria Could Improve Patient Safety

Malaria, a serious illness that often leads to death, is spread by a specific mosquito species that infect humans with a parasite. Other transmission modes include blood transfusions, organ transplants,... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The medical office procedure detects the key biomarker in Parkinson’s and related neurodegenerative diseases (Photo courtesy of BIDMC)

Simple Skin Biopsy Test Detects Parkinson’s and Related Neurodegenerative Diseases

Parkinson's disease and a group of related neurodegenerative disorders known as synucleinopathies impact millions globally. These conditions, including Parkinson’s disease (PD), dementia with Lewy bodies... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.